research The Importance of Vitamin-D in Androgenic Alopecia and Telogen Effluvium
Higher Vitamin-D levels may help treat certain types of hair loss.
Search
for
Sort by
Research
420-450 / 1000+ results
research The Diagnostic Value of Serum Ferritin for Telogen Effluvium: A Cross-Sectional Comparative Study
Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.
research Serum 25 hydroxy vitamin D level in patients with telogen effluvium
People with Telogen Effluvium have lower vitamin D levels.
research Telogen effluvium incidence in women wearing hijab compared to non-hijab: A cross-sectional study
Wearing a hijab is linked to a higher risk of hair loss.
research Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia
Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.
research Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research Efficacy and Safety of Omega 3 Fatty Acid in the Treatment of Telogen Effluvium in Middle Aged Women
Omega-3 fatty acids may help manage hair loss in middle-aged women.
research Dengue-Associated Telogen Effluvium Causing Body Dysmorphic Disorder
Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.
research TRICHOSCOPIC COMPARISON BETWEEN TELOGEN EFFLUVIUM AND ANDROGENIC ALOPECIA
Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.
research Telogen Alopecia From UV Rays
UV rays can cause a type of hair loss known as telogen alopecia.
research Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned?
Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.
research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.
research Characteristics of telogen effluvium in COVID-19 in western Iran (2020)
COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.
research Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.
research The Role of the VEGF, KGF, EGF, and TGF-β1 Growth Factors in the Pathogenesis of Telogen Effluvium in Women
Certain growth factors significantly affect hair loss in women with telogen effluvium.
research Telogen effluvium as the first symptom of Crohn's disease in a child.
Hair loss in a child was an early sign of Crohn's disease.
research Telogen effl uvium as the fi rst symptom of Crohn's disease in a child
Hair loss can be an early sign of Crohn's disease in children.
research Evaluation of the efficacy of a food supplement on subjects with acute telogen effluvium
The food supplement may help reduce hair shedding and improve hair growth.
research Prospects for the use of physiotherapy methods in the treatment of telogen alopecia
Physiotherapy methods can effectively stimulate hair growth in telogen alopecia.
research Comparative analysis of various hair peptide serums in managing telogen effluvium in females: Efficacy, safety, and patient satisfaction
The cytokine and peptide serum was most effective in reducing hair loss and improving hair growth.
research Telogen Effluvium Associated With Weight Loss: A Single Center Retrospective Study
Weight loss can cause temporary hair loss, especially in women and older adults.
research Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research A hair loss pandemic: 19 cases of COVID-19 induced telogen effluvium
COVID-19 can cause hair loss in both severe and mild cases, often affecting women.
research COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.
research Role of ferritin, vitamin D, and thyroid dysfunction in telogen effluvium among the hospital population in Western Saudi Arabia: a case–control study
Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.
research Oral minoxidil use in androgenetic alopecia and telogen effluvium
research Female pattern baldness in men
Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.
research Is Androgenetic Alopecia a Photoaggravated Dermatosis?
Sunlight worsens hair loss; protect scalp.
research Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey among Dermatologists in Saudi Arabia
Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.
research Hair extensions: a concerning cause of hair disorders
Hair extensions can cause hair loss and scalp damage, and these problems might be more common than people realize.